Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...
Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, biopsy, and various therapies. Combining therapies with complementary ...
Multiple antigen stimulating cellular therapy (MASCT)-I for metastatic urothelial carcinoma (mUC): A multicenter, phase I study (MASCT-I-1001). This is an ASCO Meeting Abstract from the 2023 ASCO ...
At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...
Genitourinary tuberculosis (GUTB) comprises a severe form of extrapulmonary tuberculosis that primarily affects the kidney, urinary tract and genital organs. Caused by Mycobacterium tuberculosis, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results